Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SAMSCA vs SATRALIZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SAMSCA vs SATRALIZUMAB: Safety Overview

Metric SAMSCA SATRALIZUMAB
Total FAERS Reports 236 219
Deaths Reported 53 16
Death Rate 22.5% 7.3%
Hospitalizations 34 108
Average Patient Age 69.1 yrs 51.6 yrs
% Female Patients 50.4% 82.1%
Manufacturer N/A Genentech, Inc.
Route N/A SUBCUTANEOUS
Marketing Status N/A Prescription